SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT00966771

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception

The purpose of this study is to see if women presenting for emergency contraception (EC) and choose the copper intrauterine device (IUD) will have fewer unplanned pregnancies in the next year compared to women who choose oral levonorgestrel for EC. The study will also compare use of an effective method of contraception in the year after they received EC.

NCT00966771 Pregnancy
MeSH: Emergencies

2 Interventions

Name: Copper T380 IUD

Description: copper T 380 IUD

Type: Drug

IUD

Name: Oral levonorgestrel

Description: 1.5 mg

Type: Drug

Oral levonorgestrel


Primary Outcomes

Measure: Unplanned pregnancy

Time: within 12 months of presenting for EC

Secondary Outcomes

Measure: Use of an effective method of contraception in the year following use of emergency contraception.

Time: 12 months

Measure: IUD expulsion, removal or perforation

Time: 12 months

Time Perspective: Prospective

Other


There is one SNP

SNPs


1 T380A

The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception The purpose of this study is to see if women presenting for emergency contraception (EC) and choose the copper intrauterine device (IUD) will have fewer unplanned pregnancies in the next year compared to women who choose oral levonorgestrel for EC. --- T380A ---



HPO Nodes